Objective First-phase ejection fraction (EF1) is a novel measure of early left ventricular systolic dysfunction. We investigated determinants of EF1 and its prognostic value in aortic stenosis.

It doesn’t seem like the New York Mets are in any rush to keep Pete Alonso around — at least not for the kind of money he’s expecting. That alone says a lot. Alonso has been the face of their lineup ...

A jury awarded $10 million to former first grade Virginia teacher Abby Zwerner, who was shot and seriously wounded by a 6-year-old student in 2023, in a civil case that accused the school's former ...

EMBED <iframe src="https://archive.org/embed/ReaderRabbitPersonalised1stGrade" width="560" height="384" frameborder="0" webkitallowfullscreen="true ...

Abigail Zwerner, the former Virginia teacher who was shot by a 6-year-old boy at school two years ago, told civil jurors she thought she was dead or about to die during the incident. NBC News' Gary ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A sign outside the ...

Background: First-phase ejection fraction (EF1) has been recently demonstrated to sensitively detect early cardiac systolic dysfunction. However, the value of EF1 in predicting myocardial fibrosis (MF ...

Math has a terrible reputation. Many people are convinced that math is either boring or too difficult. Fortunately, young children aren’t jaded—yet! Math learning doesn’t start with numbers on a ...

Colliding beams of lead create fast-moving, short-lived gold ions. Understanding the process could help to refine particle-accelerator experiments. The dream of seventeenth-century alchemists has been ...

A dad in Virginia ended up turning to social media for help after becoming confused by a first-grade math problem. Math seems to be a problem for many young Americans. In 2022, the Programme for ...

BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation ...